Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik Daub

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Nucleic Acids Research|October 25, 2003
Exploiting features of adenovirus replication to support mammalian kinase productionMatt Cotten, Kerstin Stegmueller, Jan Eickhoff, et al.
Chemistry & Biology|May 26, 2004
Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitorsStephanie Blencke, Birgit Zech, Ola Engkvist, et al.
Molecular & Cellular Proteomics : MCP|April 17, 2009
Large-scale proteomics analysis of the human kinomeFelix S Oppermann, Florian Gnad, Jesper V Olsen, et al.
Molecular & Cellular Proteomics : MCP|June 3, 2008
Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomicsPhilipp Mertins, H Christian Eberl, Jörg Renkawitz, et al.
Molecular Cell|August 12, 2008
Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycleHenrik Daub, Jesper V Olsen, Michaela Bairlein, et al.
Molecular & Cellular Proteomics : MCP|October 12, 2004
Chemical proteomic analysis reveals alternative modes of action for pyrido[2,3-d]pyrimidine kinase inhibitorsJosef Wissing, Klaus Godl, Dirk Brehmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 12, 2003
An efficient proteomics method to identify the cellular targets of protein kinase inhibitorsKlaus Godl, Josef Wissing, Alexander Kurtenbach, et al.
Cancer Research|February 8, 2005
Cellular targets of gefitinibDirk Brehmer, Zoltán Greff, Klaus Godl, et al.
Cancer Research|March 15, 2008
AXL is a potential target for therapeutic intervention in breast cancer progressionYi-Xiang Zhang, Peter G Knyazev, Yuri V Cheburkin, et al.
The Journal of General Virology|February 27, 2003
Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A proteinBirgit Zech, Alexander Kurtenbach, Nicole Krieger, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Nucleic Acids Research|October 25, 2003
Exploiting features of adenovirus replication to support mammalian kinase productionMatt Cotten, Kerstin Stegmueller, Jan Eickhoff, et al.
Chemistry & Biology|May 26, 2004
Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitorsStephanie Blencke, Birgit Zech, Ola Engkvist, et al.
Molecular & Cellular Proteomics : MCP|April 17, 2009
Large-scale proteomics analysis of the human kinomeFelix S Oppermann, Florian Gnad, Jesper V Olsen, et al.
Molecular & Cellular Proteomics : MCP|June 3, 2008
Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomicsPhilipp Mertins, H Christian Eberl, Jörg Renkawitz, et al.
Molecular Cell|August 12, 2008
Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycleHenrik Daub, Jesper V Olsen, Michaela Bairlein, et al.
Molecular & Cellular Proteomics : MCP|October 12, 2004
Chemical proteomic analysis reveals alternative modes of action for pyrido[2,3-d]pyrimidine kinase inhibitorsJosef Wissing, Klaus Godl, Dirk Brehmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 12, 2003
An efficient proteomics method to identify the cellular targets of protein kinase inhibitorsKlaus Godl, Josef Wissing, Alexander Kurtenbach, et al.
Cancer Research|February 8, 2005
Cellular targets of gefitinibDirk Brehmer, Zoltán Greff, Klaus Godl, et al.
Cancer Research|March 15, 2008
AXL is a potential target for therapeutic intervention in breast cancer progressionYi-Xiang Zhang, Peter G Knyazev, Yuri V Cheburkin, et al.
The Journal of General Virology|February 27, 2003
Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A proteinBirgit Zech, Alexander Kurtenbach, Nicole Krieger, et al.
Pageof 5